Pacific Biosciences
PACB
PACB
101 hedge funds and large institutions have $193M invested in Pacific Biosciences in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 109 → 101 (-8)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
86% less call options, than puts
Call options by funds: $57K | Put options by funds: $409K
Holders
101
Holding in Top 10
2
Calls
$57K
Puts
$409K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$8.35M | |
| 3 | +$4.45M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.3M |
| 5 |
Blackstone Inc
New York
|
+$3.51M |
Top Sellers
| 1 | -$8.44M | |
| 2 | -$1.18M | |
| 3 | -$704K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$416K |
| 5 |
Two Sigma Investments
New York
|
-$370K |